aortic aneurysm, 5% also have a descending thoracic aneurysm~; in patients with a descending thoracic aneurysm, i3% to 29% also have abdominal involvement. [2] [3] [4] [5] [6] In the early 1980s, Crawford advocated simultaneous open thoracic and abdominal aortic repair as the treatment of choice in patients with multilevel aortic disease. 7,8 Sequential repair can also be performed, but this approach requires two major surgical interventions, and rupture of the residual aneurysm can occur while waiting the second operation.S, 7 Crawford fotmd that 30% of early postoperative deaths after isolated repair of a descending thoracic aneurysm were caused by rupture of an untrcated infrarenal aneurysm, s
Transluminally placed endovascular grafts have recently been developed for repair of thoracic aortic aneurysms with encouraging early rcsults. 9a° In an attempt to decrease the risk associated with either a simultaneous thoracotomy and laparotomy or sequential major operations in patients with multilevel aortic disease and to make treatment available to patients with otherwise prohibitive comorbidities, we have begun to look at alternatives to conventional surgical treatment. In the current study, we found that combined retroperitoneal abdominal aortic replacement with endovascular stent-graft placement into the descending thoracic aorta can effectively exclude both areas of aortic disease without the added morbidity of a thoracic incision or second operation.
MATERIAL AND METHODS
Patient population. From January 1994 to March 1996, 18 patients with coexisting abdominal aortic and descending thoracic aneurysmal disease underwent conventional retropcritoncal abdominal aortic replacement and endovascular stent-graft placement into the descending thoracic aorta through a 10 mm Dacron side limb offthe abdominal graft. A transperitoneal approach was used if necessary to adequately visualize the abdominal aorta. There were 14 men and 4 women, with a mean age of 71 + 6 (+ 1 SD) years (range, 62 to 83 years). Seventeen patients (94%) had significant comorbidities that required treatment, including coronary artery disease (12 patients), chronic obstructive pulmonary disease (COPD) (8) , hypertension (15) , and diabetes (3) . Twelve patients (67%) had a significant smoking history (68 + 22 pack-years). During this period at our institution, one patient elected to undergo a simultaneous open thoracic and abdominal aortic aneurysm repair, and two other patients underwent sequential open repair 6 to 8 weeks apart because their thoracic aneurysm was not appropriate for stent-graft placement (inadequate proximal neck).
Abdominal aortic disease including infrarenal (13 patients), juxtarenal (3), and suprarenal (1) aneurysms, and one patient had severe aortoiliac occlusive disease. Ten patients had extensive disease of either one or both iliac arteries that required treatment. Mean abdominal aortic diameter in patients with aneurysms was 5.6 _+ 1.9 cm (range, 3.5 to 9.5 cm); 10 aneurysms were greater than 5 cm and six were greater than 6 cm. Descending thoracic disease included atherosclerotic aneurysmal disease (12 patients), intramural hematomaflpenetrating ulcer (5), and chronic post-traumatic aneurysm (1). The thoracic aneurysm involved the distal descending aorta in five patients, mid-descending aorta in seven patients, and proximal descending aorta in six patients. In three patients, the thoracic disease spanned all three segments. Length of the thoracic aneurysm averaged 8.9 _+ 4.3 cm (range, 3.2 to 20 cm). The mean diameter of the thoracic aneurysm (13 patients) was 6.8 -+ 1.5 cm (range, 5 to 11 cm); only two aneurysms were less than 6 cm. Mean thoracic aortic diameter in patients with penetrating ulcers (five paticnts) was 5.5 + 0.5 cm (range, 5 to 6 cm). The thoracic aorta proximal to the diseased segment was 3.2 + 0.4 cm in diameter (range, 2.0 to 3.8 cm). The thoracic aorta distal to the diseased segment was also 3.2 + 0.4 cm in diameter (range, 2.4 to 3.8 cm).
Preoperative evaluation. Before surgery, a spiral computed tomographic (CT) scan was obtained of the thoracoabdominal aorta to measure thoracic and abdominal aortic diameter, evaluate the branch vessels and iliac arteries, and provide a three-dimensional reconstruction of the descending thoracic aorta to measure aneurysm length and diameter. An aortogram was obtained to identify the rcnal and visceral vessels and to determine the relationship of the proximal thoracic aneurysm neck to the left subclavian artery and celiac axis. One to 2 cm ofnonaneurysmal aorta is necessary both proximal and distal to the aneurysm to allow safe deployment without the need for a preliminary subclavian-to-carotid transposition or bypass and without compromise to the visceral circulation. 1°,11 It is also helpful to localize patent intercostal arteries so that attempts can be made to preserve these at the time of stent-graft deployment; we do not, however, perform selective intercostal angiographic evaluation. If large intercostal arteries are noted before surgery, excess distal stent-graft length is avoided to prevent intercostal occlusion; alternatively, an uncovered stent can be used to anchor the stent-graft at the proximal or distal neck of the aneurysm, allowing perfusion in a critical intercostal artery. Patients were not considered appropriate for endovascular stent-graft placement in the absence of an adequate aneurysm neck (inadequate length or excess diameter) or with inappropriate morphologic features (e.g. extensive chronic aortic dissections).
Fabrication of endovascular stent-grafts. Stent-grafts were individually fabricated as previously described with commercially available products. 911 Multiple self-expanding "Z"-stents were combined to yield the desired length, and a woven Dacron graft (Cooley Veri-Soft, Meadox Medicals, Inc., Oaldand, NJ.), that had been ironed to flatten the crimps and reduce its profile was attached to the stainless-steel endoskeleton with interrupted 5-0 polypropylene sutures (Fig. 1) . Uncrimped grafts are now available and will be used for stent-graft fabrication in the future. On the basis of preoperative CT scan measurements, stent-graft length was manufactured to be approximately 3 to 4 cm longer than the segment of aortic disease; this allowed the ends of the stentgraft to anchor to the proximal and distal necks of the aneurysm. Stent-graft diameter was oversized by 2 to 3 mm to create an effective friction seal at each end. Stent-grafts could be designed to taper or reverse-taper as necessary to match each patient's anatomy. After sterilization, the stent-graft was radially compressed and loaded into a 20F to 28F Teflon sheath (loading cartridge) for later deployment.
Surgical technique. A double lumen endotracheal tube was usually inserted, and cardiopulmonary bypass standby was available for every case. Continuous radial artery and pulmonary artery monitoring were used, as was transesophageal echocardiography to monitor cardiac function. Patients were prepped and draped for combined thoracic and retroperitoneal incisions in the 60-degree right lateral decubitus position. A cell-saver collection system was helpful to minimize transfusion requirements during aortic replacement and catheter manipulation. Abdominal aortic replacement was performed using a standard retroperitoneal approach; rarely was a transperitoneal approach necessary for adequate visualization of the abdominal aorta. With moderate systemic heparinization (100 IU/kg), the abdominal aorta was replaced with a Dacron tube graft in eight patients, aortobiiliac graft in eight patients, aortobifemoral graft in one patient, and the remaining patient required a bifurcated graft to the left iliac and the right femoral artery. The patient with a suprarenal aneurysm had previously undergone an aortobifemoral graft for occlusive disease and required supraceliac cross-clamping and renal reimplantation. In all patients, after completion of the distal anastomosis, a 10 mm Dacron graft (length, approximately 10 to 15 cm) was anastomosed in an end-to-side fashion to the main trunk of the abdominal graft (Fig. 2 ). The distal end was then secured with a vessel clamp. The graft was then used as the side limb through which the stent-graft could be placed. If a bifurcated graft was required, it was also possible to use one limb of the graft (9 mm or greater) for endovascular access, although use of a side limb is preferable as it allows earlier return of flow to both legs.
Endovascular stent-graft placement. Before endovascular manipulation, full systemic heparinization (total 200 to 300 IU/kg) was achieved. Using the Seldinger technique, a 9F introducer sheath was inserted into the side limb graft, a 5F pigtail was introduced into the aortic arch over a guidewire under fluoroscopic guidance, and an intraoperative angiogram was obtained to accurately localize the proximal aneurysm neck. A portable C-arm image intensifier with digital road-mapping capabilities was used. A 0.035-inch "super-stiff" guidewire was then exchanged for the introducer, and the proximal side limb was clamped to prevent blood loss. A carefullysized transverse incision was made in the side limb to allow passage ofa 20F to 28F Teflon delivery sheath with a tapered dilator over the guidewire. The delivery sheath had a fenestrated plastic cover (one-way valve apparatus, Cook Urological, Inc., Bloomington, Ind.) secured to its end to provide hemostatis; the one-way valve allowed antegrade catheter insertion but prevented retrograde blood loss during catheter exchanges. The dilator and guidewire were removed and the compressed stent-graft introduced into the delivery sheath with a solid Teflon rod or "pusher."
Under fluoroscopic guidance, the stent-graft was advanced up the delivery sheath using the Teflon pusher until it was 1.5 to 2 cm proximal to the aneurysm neck. The location of the proximal neck was based on landmarks obtained on the intraoperative angiogram. Fortunately, the anatomy of the distal aortic arch and proximal descending thoracic aorta was relatively stable during passage of the delivery sheath. If anatomic deformation by the sheath was suspected, another angiogram was obtained through the sheath prior to stent-graft deployment. Controlled hypotension was induced with nitroprusside or esmolol (mean arterial pressure, 50 to 60 mm Hg) to minimize stent migration during deployment. To deploy the stent, the delivery sheath was withdrawn rapidly while the pusher was held station- If stent-graft position was too distal such that the proximal aneurysm was not excluded, or it was too proximal such that the distal aneurysm was not excluded, additional smaller stent-grafts were placed to bridge the gap. After removal of all catheters and heparin reversal, the side limb was over sewn near its anastomosis to the abdominal graft, the incision was closed, and the patient was traalsferred to the intensive care unit. If further manipulation was considered in the future (i.e., for treatment of other aneurysms that currently were not of adequate size to warrant intervention), the side limb was left intact and buried just below the fascia or in the subcutaneous tissue for easy access.
Postoperative evaluation. Before discharge, aortography and a repeat spiral CT scan were performed to document aneurysm exclusion. The patients were then studied at 2 months with a chest radiograph, at 6 months and 1 year with a radiograph, spiral CT scan, and arteriogram, then annually thereafter with a radiograph and spiral CT scan. The operative and radiologic protocol was approved by the Stanford University Medical Center Committee on the Use of H u m a n Subjects in Research, and informed consent was obtained before surgical intervention and radiographic studies.
Statistical analysis. All continuous data are reported as mean + one standard deviation and ratios as mean _+ 70% confidence limits. Actuarial life-table survival data were calculated using commercially available software (SPSS, Chicago, Ill.) and variability expressed as _ one standard error of the mean.
R E S U L T S
Stent-graft deployment was technically successful in all cases; 13 patients were adequately treated with one stent, whereas five patients required two stentgrafts to exclude the area of disease. Mean stent-graff length was 12.2 + 4.2 cm (range, 7.5 to 20 cm) and diameter was 3.3 + 0.4 cm (range, 2.4 to 3.8 cm). Complete aneurysm exclusion was achieved at the time of operation in 17 patients (94%) and have remained so throughout the follow-up period. One patient has a residual false channel between the stentgraft and native aortic wall proximally that remains unchanged 21 months after surgery. This 66-yearold man, who was refused an open thoracic repair because of severe COPD, underwent stent-grafting February 1997 Fig. 3 . Preoperative thoracic (A, magnified) and abdominal (B) cross-sectional contrast CT scans demonstrate 11 cm and 5 cm aneurysms, respectively, in an 83-year-old man.
for two large penetrating ulcers. At the completion o f the procedure, an angiogram demonstrated that the ulcers were excluded, but there was also a small, low-flow residual false channel. We are currently observing this patient at 6 -m o n t h intervals with contrast C T scans. I f the aorta enlarges, a saccular false aneurysm develops at either end o f the stent-graft, or flow is reestablished to the ulcers, additional stentgrafts will be placed. N o patients have required further surgical intervention to treat their aortic disease.
Overall, one patient died, resulting in a hospital mortality rate o f 6% + 6%. The one postoperative death occurred in a 66-year-old man 31 days after complex redo suprarenal aneurysm resection and thoracic stent-grafting; splenectomy was required on the first postoperative day for an intraoperative injury. The postoperative course was complicated by a severe coagulopathy and systemic hypotension requiring inotropic agents; the patient ultimately died offungal sepsis with multisystem organ failure. In the 17 survivors, hospital stay, intensive care unit stay, and mechanical ventilation averaged 12 + 9 days, 5 _+ 5 days, and 3 -+ 4 days, respectively. Thirteen patients (72%) were extubated within 48 hours, and nine (50%) required less than 72 hours of intensive care. Intraoperative transfusion requirements were 3.7 _+ 3.1 units (packed red blood cells), and, excluding the patient who died with a prolonged coagulopathy that required 79 units in the postoperative period, mean postoperative transfusion requirements were 2.6 -+ 2.2 units.
Nine postoperative complications occurred in 6 patients (33%), including respiratory insufficiency, small bowel obstruction requiting laparoscopic lysis of adhesions, cerebrovascular accident, paraplegia, coagulopathy (two patients), splenic injury, dissection of the aorta proximal to the stent-graft, and retroperitoneal hematoma that required surgical evacuation 3 months aftcr surgery.
A 62-year-old man with severe COPD required 18 days of ventilatory support for respiratory insufficiency before full recovery. This patient also had a retrograde subintimal aortic dissection proximal to the level of stent-graft placement on his predischarge CT scan. He remained asymptomatic, and subsequent CT scans and arteriograms demonstrated complete resolution within 4 months.
A 72-year-old woman with a history of transient ischemia attacks but no radiologic evidence of carotid disease developed a left hemispheric stroke 9 hours after the procedure. A brain CT demonstrated multiple old bilateral infarcts; a residual left-sided strength deficit persists. Paraplegia occurred in the 66-year-old patient described above as the operative death. This patient had a 12.5 cm stent-graft placed into the thoracic aorta. It is unknown whether distal embolization, hypotension, or intercostal artery interruption was responsible for the spinal cord injury in this patient.
A 74-year-old woman with no preexisting hematologic disorder suffered a severe thrombotic coagulopathy during abdominal aortic replacement. Proximal aortic and distal iliac thrombosis occurred after suprarenal cross-clamping to repair her juxtarenal aneurysm despite adequate anticoagulation; activated clotting time was 280 seconds at the time of thrombosis (120 seconds baseline). Thrombectomy was required to restore distal flow. Due to the intraoperative complication and prolonged suprarenal cross-clamp time (89 minutes), stent-graft placement was deferred to a later date (19 days after surgery) on a second admission. At the initial operation, the Dacron side limb was tunneled through the fascia into the subcutaneous plane. When the patient returned to the operating room, relaparotomy was not required; a subcutaneous dissection allowed easy access to the side limb, which, after thrombectomy, allowed routine stent-graft placement. Hospital stay was 7 days after the abdominal aneurysm resection and 4 days after stent-graft placement. All other patients underwent stent-graft placement during the same anesthetic period.
There have been no late deaths to date, and all 17 hospital survivors are currently well 14 -+ 8 months (range, 3 to 29 months) after surgery. The actuarial survival rate is 92% _+ 8% at 12 months. Postoperative serial radiographic studies have demonstrated no stent migration or change in stent configuration in the thoracic aorta and no pseudoaneurysm formation or aneurysm expansion in either the abdominal or thoracic aorta. Approximately one half of the patients have experienced shrinkage of the thrombosed thoracic aortic aneurysm sac, whereas in the others its size has remained the same.
D I S C U S S I O N
Endovascular stent-grafts have recently been developed to exclude disease of the descending thoracic aorta, and although long-term follow-up is limited, early experimental and clinical results have been encouraging. 9,1°,12,13 Since July 1992 stent-graft repair for descending thoracic aortic disease has been performed at Stanford in 81 patients, n The overall hospital mortality rate is 9% + 3%, the paraplegia rate is 4% +_ 2%, and the stroke rate is 5% + 3%. Current actuarial survival estimates are 87% _+ 4% at 1 year and 81% _+ 6% at 3 years, but mean follow-up is only 13.2 months. In an attempt to decrease the morbidity rate associated with combined descending and abdominal aortic replacement that requires both a thoracotomy and laparotomy, we have applied endovascular techniques to patients with multilevel aortic disease.
The operative mortality rate for patients undergoing elective open repair of an isolated descending thoracic aortic aneurysm is 3% to 12% 6'14-18 whereas that following conventional abdominal aortic resection is 2% to 5%. 19-22 Historically, in patients with combined descending thoracic and abdominal aortic aneurysms, both could be repaired simultaneously through separate incisions or the operations could be staged, usually 6 to 8 weeks apart, with the order of operation determined by symptoms and relative aneurysm size. In asymptomatic patients, Crawford recommended repair of the thoracic aorta initially. 7-s While awaiting the second operation, the abdominal aneurysm is easier to observe, and if symptoms or rupture occur patients could potentially survive for periods sufficient to attempt repair. In contrast, thoracic aneurysms are more likely to rupture without warning and are rapidly fatal within minutes.
More than 60% of patients who undergo repair of a descending thoracic aneurysm have multifocal aortic disease, half of which involves the infrarenal aorta. 7 Crawford s noted in his series of 112 patients who underwent isolated repair of a descending thoracic aneurysm, that of 10 patients who died within 30 days of operation, 30% died as the result of a ruptured infrarenal aneurysm. F o r these reasons, Crawford performed simultaneous repair through separate thoracic and abdominal incisions in 24 patients who he felt were good surgical risks and continued to do well in the operating room after the first replacement; the 30 day mortality rate was 8%. 7 In his series, the mortality rates in patients who underwent simultaneous versus staged operations for all types of multilevel aortic disease were 10% and 16%, respectively.
In the current series, our mortality rate was 6% + 6%, which compares favorably with Crawford's results; however, many of these patients had been considered inoperable for standard thoracic aortic replacement by cardiovascular surgeons before surgery because of their poor underlying cardiopulmonary status. In patients of acceptable surgical risk, we currently recommend thoracic aortic replacement (either open or endovascular) in all symptomatic patients or if the aneurysm is greater than 6 cm or twice the size of a relatively normal contiguous aortic segment. 6 Penetrating ulcers or documented enlargement should also prompt surgical considcration. Concurrent abdominal aortic replacement should be considered if it is greater than 5 cm, if it has been increasing in size, or if the patient's associated iliofemoral disease precludes safe access to the more proximal aortic tree (extensive intraluminal thrombus or atherosclerotic disease). In our series, five patients had aneurysms between 4 and 5 cm, four between 5 and 6 cm, and six had large aneurysms (greater than 6 cm). Two patients had smaller aneurysms (3.5 cm each) that would not have been repaired, but iliofemoral atherosclerotic disease prevented safe passage of the stent-graft insertion system. Conventional descending aortic resection is associated with a 5% risk of severe renal dysfunction that requires dialysis, 6,1s whereas the risk is less than i% with elective infrarenal replacement. 19-23 Because thoracic stent-grafting does not require a suprarenal cross-clarnp (minimizing distal aortic hypotension), there should be no added risk of renal dysfunction over that associated with abdominal aneurysm resection alone, with the possible exception of contrastinduced nephropathy. One patient in our series developed renal dysfunction in association with multisystem organ failure after redo suprarenal aneurysm repair. This was most likely related to suprarenal cross-clamping with renal reimplantation, contrastinduced nephropathy, sepsis with systemic hypotension requiring inotropic support, and a severe coagulopathy in the postoperative period.
Although thc risk of paraplegia with abdominal aortic replacement is minimal (0% to 0.2%), 23,24 the incidence with descending thoracic replacement averages 4% (range, 0% to 18%; 4% at our institution). 3,6,14,18 With stent-grafts, the opportunity to reimplant intercostal vessels is not available, but the aorta does not need to be clamped, thus avoiding distal hypotension during the operation. One patient in our series was noted to be paraplegic in the early postoperative period. After redo suprarenal aneurysm repair, a 12.5 cm stent-graft was placed from the proximal to distal descending aorta. In this particular patient, there was no evidence of critical intercostal arteries near the aneurysm on preoperative studies, but selective intercostal angiography was not performed. The artery of Adamldewicz is present in 80% of patients, and when present it arises between T9 and T12 in 75%, between L1 and L2 in 10%, and between T5 and T8 in 15%. 6 In chronic thoracic aneurysms, the intercostal arteries usually thrombose within the diseased segment, leaving the spinal cord dependent on proximal and distal collateral vessels. If intercostal arteries are noted angiographically before the procedure, excess distal stent-graft length should be avoided to prevent occlusion. Uncovered stents can also be used as the proximal or distal anchor for patients in whom stent-graft location is sufficiently close to an important intercost~d artery, although this is less desirable. Whether paraplegia in our patient was a result of distal embolization or obliteration of an unidentified intercostal artmT or intraoperative or postoperative hypotension remains unknown.
Combined conventional abdominal aortic replacement with descending thoracic aortic stentgraft placement is feasible and can safely be performed in high-risk patients who otherwise may not be considered candidates for open repair. Although long-term results remain unknown, we believe that the early results are encouraging and warrant further investigation and application of this new approach: We are continuing to monitor these patients and perform this procedure as part of an investigational protocol approved by the Institutional Review Board of the Stanford University Medical Center, and an application for an Investigational Device Exception has been submitted to the Food and Drug Administration. The 1-year actuarial survival rate of 92% _+ 8% compares favorably with that of patients who undergo isolated standard descending thoracic repair (85 %) and patients with multifocal aortic disease who undergo replacement of both aneurysms (75%) or only one aneurysm (5 5%). 3, 6, 7, 14, 16 It is interesting to note that in patients who underwent planned resection of only one aneurysm, the 3-year and 7-year survival rates were 48% and 12%, respectively, compared with 32% and 2% for patients who received no treatment but 64% and 34% in patients who underwent resection of both aneurysms. 7 Thus complete repair of multilevel disease portends the best longterm prognosis and should be the treatment of choice, but their 7-year survival rate of only 34% underscores the poor general medical status of even the best candidates for combined resection.
The less-invasive approach described in this re-port may be associated with fewer early complications and deaths than simultaneous or sequential open thoracic and abdominal repair in high-risk patients, but the long-term efficacy and clinical outcome remains entirely unknown. Long-term studies will be required before this approach can bc adopted in all patients with multifocal aortic disease or in anything other than an experimental protocol. In a young patient who is otherwise healthy, conventional open repair of a concurrent thoracic and abdominal aneurysm, either simultaneous or staged, may provide the best opportunity for long-term success. Elderly patients with coexisting cardiopulmonary disease would most benefit from a less-invasive, but nonetheless complete, repair of this challenging disease.
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